clopidogrel + aspirin
Sponsors
University of Massachusetts, Worcester, Centre Hospitalier de PAU, Juan J Badimon, University of Florida, Sunnybrook Health Sciences Centre
Conditions
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Blood PlateletsClopidogrelCoronary Artery DiseaseHigh Bleeding RiskIntracranial ArteriosclerosisIntracranial AtherosclerosisStroke
Phase 3
Phase 4
Anticoagulant Treatments and Percutaneous Coronary Angioplasty
TerminatedNCT00669149
Start: 2008-06-30End: 2013-08-03Updated: 2019-05-17
Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
CompletedNCT01823510
Start: 2013-07-31End: 2016-05-10Updated: 2017-12-08
Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR
Not yet recruitingNCT06763744
Start: 2025-06-01End: 2029-12-31Target: 3000Updated: 2025-05-18
Unknown Phase
PACT (Platelet Activity After Clopidogrel Termination)
CompletedNCT00619073
Start: 2008-04-30End: 2009-05-31Updated: 2018-05-31
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy in Symptomatic ICAD
RecruitingNCT06714526
Start: 2025-10-07End: 2027-08-31Target: 100Updated: 2025-11-20